Nasus Pharma Ltd.
(NYSE Mkt: NSRX)
Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
6.850
-0.140
(-2.00%)
Range
6.850 - 6.850
(-%)
Open
6.850
Previous Close
6.990
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
963
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 04:58.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
